Russell Investments Group
ETON icon

Russell Investments Group’s Eton Pharmaceutcials ETON Stock Holding History

Russell Investments Group’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.9K Sell
2,670
-47,024
-95% -$822K ﹤0.01% 3219
2025
Q4 		$840K Sell
49,694
-5,171
-9% -$91K ﹤0.01% 2303
2025
Q3 		$1.19M Buy
54,865
+36,753
+203% +$610K ﹤0.01% 2134
2025
Q2 		$258K Buy
+18,112
New +$286K ﹤0.01% 2575
2021
Q3 		– Sell
-36,079
Closed -$222K – 3084
2021
Q2 		$222K Hold
36,079
– – ﹤0.01% 2873
2021
Q1 		$264K Hold
36,079
– – ﹤0.01% 2756
2020
Q4 		$293K Sell
36,079
-45,626
-56% -$352K ﹤0.01% 2636
2020
Q3 		$645K Buy
+81,705
New +$558K ﹤0.01% 2277

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Russell Investments Group's ETON Position: Q1 2026 in Review

Russell Investments Group reduced its Eton Pharmaceutcials (ETON) stake by 95% in Q1 2026, selling an estimated $822K and leaving 2,670 shares worth $65.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3219.

Russell Investments Group first reported a position in ETON in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.19M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Russell Investments Group held 2,670 shares of Eton Pharmaceutcials worth $65.9K as of Q1 2026.
  • Russell Investments Group sold 47,024 Eton Pharmaceutcials shares in Q1 2026, an estimated $822K.
  • Eton Pharmaceutcials made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3219 holding.
  • Russell Investments Group first reported a position in Eton Pharmaceutcials in Q3 2020 and has held it in 8 quarters since.
  • Russell Investments Group's Eton Pharmaceutcials position peaked at $1.19M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.